Putnam Investments’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-8,210
Closed -$460K 828
2020
Q4
$460K Sell
8,210
-4,318
-34% -$230K ﹤0.01% 740
2020
Q3
$694K Sell
12,528
-238
-2% -$12.3K ﹤0.01% 755
2020
Q2
$579K Sell
12,766
-42,241
-77% -$1.89M ﹤0.01% 787
2020
Q1
$2.43M Sell
55,007
-869
-2% -$33.9K 0.01% 565
2019
Q4
$2M Buy
55,876
+27,507
+97% +$1.02M ﹤0.01% 718
2019
Q3
$992K Buy
28,369
+313
+1% +$12K ﹤0.01% 766
2019
Q2
$1.21M Sell
28,056
-6,764
-19% -$280K ﹤0.01% 765
2019
Q1
$1.5M Buy
34,820
+4,431
+15% +$178K ﹤0.01% 730
2018
Q4
$1.11M Buy
+30,389
New +$1.13M ﹤0.01% 732

Other funds holding QGEN

Putnam Investments's QGEN Position: Q1 2021 in Review

Putnam Investments sold out of Qiagen (QGEN) in Q1 2021, closing a stake of 8,210 shares — an estimated $460K sold.

Putnam Investments first reported a position in QGEN in Q4 2018 and held it in 9 quarters. The position peaked at $2.43M in Q1 2020. 274 funds tracked by Wall St. Rank hold QGEN as of Q1 2021.

  • Putnam Investments reported no remaining Qiagen position as of Q1 2021 after selling out during the quarter.
  • Putnam Investments sold 8,210 Qiagen shares in Q1 2021, an estimated $460K.
  • Putnam Investments first reported a position in Qiagen in Q4 2018 and held it in 9 quarters.
  • Putnam Investments's Qiagen position peaked at $2.43M in Q1 2020.
  • 274 funds tracked by Wall St. Rank held Qiagen as of Q1 2021.

Based on Putnam Investments's 13F filing for Q1 2021, filed 17 May 2021.